Literature DB >> 22669433

[Botulinum toxin in the head and neck region].

R Laskawi1.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22669433     DOI： 10.1007/s00106-011-2478-6

Source DB:  PubMed          Journal:  HNO        ISSN： 0017-6192            Impact factor:   1.284


× No keyword cloud information.
  6 in total

1.  [Use of botulinum toxin in ORL departments in Germany].

Authors:  P Matthes; J Kruegel; C Karapantzou; J Winterhoff; R Laskawi
Journal:  HNO       Date:  2010-05       Impact factor: 1.284

Review 2.  [Botulinum toxin treatment in the head and neck region: current aspects, developments, and problems].

Authors:  R Laskawi
Journal:  HNO       Date:  2007-06       Impact factor: 1.284

Review 3.  [Therapeutic use of botulinum toxin in otorhinolaryngology. 2. Movement disorders of craniocervical musculature (except for mimetic musculature) and disorders of the autonomic nervous system].

Authors:  R Laskawi
Journal:  HNO       Date:  1998-04       Impact factor: 1.284

4.  [Therapeutic use of botulinum toxin in otorhinolaryngology. 1: Treatment of movement disorders of mimetic muscles].

Authors:  R Laskawi
Journal:  HNO       Date:  1998-03       Impact factor: 1.284

5.  Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery.

Authors:  A B Scott
Journal:  Ophthalmology       Date:  1980-10       Impact factor: 12.079

6.  [Involuntary lid closure caused by defective healing of facial paralysis and its treatment with botulinum toxin].

Authors:  P Roggenkämper; R Laskawi; W Damenz; M Schröder; Z Nüssgens
Journal:  Klin Monbl Augenheilkd       Date:  1991-04       Impact factor: 0.700
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.